Related Experiment Video
Updated: Jul 23, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation
G Mbalaviele1, Y Abu-Amer, A Meng
1Osiris Therapeutics, Inc., Baltimore, Maryland 21231, USA. gmbalaviele@osiristx.com
Abstract:
The nuclear receptor and transcription factor, peroxisome proliferator-activated receptor-gamma (PPAR-gamma), regulates the activity of other transcription factors in the adipogenic differentiation and inflammatory response pathways. We examined the possible function of the PPAR-gamma pathway in osteoclast (Ocl) formation from CD34(+) hematopoietic stem cells (CD34(+) HSCs), using a co-culture system comprised of human mesenchymal stem cells (hMSCs) and CD34(+) HSCs, both derived from bone marrow. Ocl formation in this co-culture system is enhanced by the addition of exogenous osteoprotegerin ligand (OPGL), an essential Ocl differentiation factor, and macrophage-colony stimulating factor (M-CSF). The data indicate that soluble OPGL (sOPGL) and M-CSF stimulate Ocl formation in the co-cultures up to 4-fold compared with CD34(+) HSCs alone treated with sOPGL and M-CSF. CD34(+) HSCs, but not hMSCs, express PPAR-gamma, and 15-deoxy-Delta(12, 14)-prostaglandin-J2 (15d-PG-J2), a PPAR-gamma agonist, completely blocked the effects of sOPGL and M-CSF on Ocl formation and activity. The inhibitory effect of 15d-PG-J2 is specific to the Ocl lineage in both human and mouse models of osteoclastogenesis. Accordingly, parallel experiments demonstrate that sOPGL activates the NF-kappaB pathway within mouse Ocl progenitors, and this effect was abolished by 15d-PG-J2. These data establish a link between PPAR-gamma and OPGL signaling within Ocl progenitors, and support a role for PPAR-gamma pathway in the modulation of osteoclastogenesis.
Insights
The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) pathway inhibits osteoclast formation. This finding links PPAR-gamma signaling to osteoclast differentiation, impacting bone remodeling and related diseases.
Area of Science:
- * Molecular biology
- * Cell biology
- * Immunology
Background:
- * Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a nuclear receptor regulating adipogenesis and inflammation.
- * Osteoclast (Ocl) formation is crucial for bone remodeling and is influenced by various signaling pathways.
Purpose of the Study:
- * To investigate the role of the PPAR-gamma pathway in osteoclast formation from CD34(+) hematopoietic stem cells (HSCs).
- * To elucidate the interaction between PPAR-gamma and osteoprotegerin ligand (OPGL) signaling in osteoclastogenesis.
Main Methods:
- * Co-culture system using human mesenchymal stem cells (hMSCs) and CD34(+) HSCs.
- * Stimulation of osteoclast formation with soluble OPGL (sOPGL) and macrophage-colony stimulating factor (M-CSF).
- * Treatment with 15-deoxy-Delta(12, 14)-prostaglandin-J2 (15d-PG-J2), a PPAR-gamma agonist, to assess its inhibitory effects.
Main Results:
- * sOPGL and M-CSF significantly enhanced osteoclast formation in co-cultures.
- * CD34(+) HSCs express PPAR-gamma, while hMSCs do not.
- * 15d-PG-J2 completely inhibited sOPGL and M-CSF-induced osteoclast formation and activity, specifically in the osteoclast lineage.
- * sOPGL-induced activation of the NF-kappaB pathway in osteoclast progenitors was abolished by 15d-PG-J2.
Conclusions:
- * The PPAR-gamma pathway plays a significant role in modulating osteoclastogenesis.
- * A direct link exists between PPAR-gamma and OPGL signaling in osteoclast progenitors.
- * PPAR-gamma agonists may represent a therapeutic target for conditions involving excessive osteoclast activity.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
TGF - β Signaling Pathway
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

